These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 20721491

  • 1. Correlation of biological serum markers with the degree of hepatic fibrosis and necroinflammatory activity in hepatitis C and schistosomiasis patients.
    Morais CN, Carvalho Bde M, Melo WG, Melo FL, Lopes EP, Domingues AL, Jucá N, Martins JR, Diniz GT, Montenegro SM.
    Mem Inst Oswaldo Cruz; 2010 Jul; 105(4):460-6. PubMed ID: 20721491
    [Abstract] [Full Text] [Related]

  • 2. Differentiating cirrhosis and chronic hepatosplenic schistosomiasis using MRI.
    Bezerra AS, D'Ippolito G, Caldana RP, Leopoldino DD, Batista GR, Borges DR, Lopes Filho Gde J, Ahmed M.
    AJR Am J Roentgenol; 2008 Mar; 190(3):W201-7. PubMed ID: 18287413
    [Abstract] [Full Text] [Related]

  • 3. Renal changes in patients with hepatosplenic schistosomiasis.
    Andrade ZA, Andrade SG, Sadigursky M.
    Am J Trop Med Hyg; 1971 Jan; 20(1):77-83. PubMed ID: 5567743
    [No Abstract] [Full Text] [Related]

  • 4. Diagnostic value of non-invasive bio-markers for stage-specific diagnosis of hepatic fibrosis in patients with advanced schistosomiasis japonica.
    Hou XY, Ellis MK, McManus DP, Wang YY, Li SD, Williams GM, Li YS.
    Int J Parasitol; 2011 Mar; 41(3-4):325-32. PubMed ID: 21145322
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the cytokines IL-10 and IL-13 as mediators in the progression of Symmers fibrosis in patients with hepatosplenic schistosomiasis mansoni.
    Brandt CT, Rino M, Pitta MG, Muniz JS, Silveira Dde O, Castro CM.
    Rev Col Bras Cir; 2010 Oct; 37(5):333-7. PubMed ID: 21180998
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ultrasonography of the liver and spleen in Brazilian patients with hepatosplenic schistosomiasis and cirrhosis.
    Pereira LM, Domingues AL, Spinelli V, McFarlane IG.
    Trans R Soc Trop Med Hyg; 1998 Oct; 92(6):639-42. PubMed ID: 10326109
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Progression of fibrosis in hepatitis C with and without schistosomiasis: correlation with serum markers of fibrosis.
    Kamal SM, Turner B, He Q, Rasenack J, Bianchi L, Al Tawil A, Nooman A, Massoud M, Koziel MJ, Afdhal NH.
    Hepatology; 2006 Apr; 43(4):771-9. PubMed ID: 16557547
    [Abstract] [Full Text] [Related]

  • 10. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.
    Omran MM, Farid K, Emran TM, Attallah AA.
    Arab J Gastroenterol; 2011 Jun; 12(2):74-9. PubMed ID: 21684477
    [Abstract] [Full Text] [Related]

  • 11. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P, Fabris C, Bitetto D, Falleti E, Avellini C, Rossi E, Smirne C, Minisini R, Pirisi M.
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [Abstract] [Full Text] [Related]

  • 12. [Functional and immunologic evaluation of prothrombin in the hepatosplenic form of schistosomiasis and hepatic cirrhosis].
    Manoukian N, Borges DR.
    Rev Paul Med; 1983 Nov; 101(5):182-5. PubMed ID: 6672979
    [No Abstract] [Full Text] [Related]

  • 13. ABO blood groups in hepato-splenic schistosomiasis.
    El Masri SH, Sharfi AR.
    J Trop Med Hyg; 1982 Oct; 85(5):223-4. PubMed ID: 6983589
    [No Abstract] [Full Text] [Related]

  • 14. Rifaximin Reduces Markers of Inflammation and Bacterial 16S rRNA in Zambian Adults with Hepatosplenic Schistosomiasis: A Randomized Control Trial.
    Sinkala E, Zyambo K, Besa E, Kaonga P, Nsokolo B, Kayamba V, Vinikoor M, Zulu R, Bwalya M, Foster GR, Kelly P.
    Am J Trop Med Hyg; 2018 Apr; 98(4):1152-1158. PubMed ID: 29436337
    [Abstract] [Full Text] [Related]

  • 15. [Serum globulin levels and intensity of hepatic fibrosis in patients with mansonic schistosomiasis].
    Correia HS, Domingues AL, Lopes EP, Morais CN, Sarteschi C, Moura IM.
    Arq Gastroenterol; 2009 Apr; 46(3):194-8. PubMed ID: 19918685
    [Abstract] [Full Text] [Related]

  • 16. Increased Hepatic Arterial Blood Flow Measured by Hepatic Perfusion Index in Hepatosplenic Schistosomiasis: New Concepts for an Old Disease.
    de Carvalho BT, Coutinho Domingues AL, de Almeida Lopes EP, Brandão SC.
    Dig Dis Sci; 2016 Jul; 61(7):2118-26. PubMed ID: 26921079
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Non-invasive fibrosis tests are correlated with necroinflammatory actvity of liver in patients with chronic hepatitis B.
    Ozyalvacli G, Kucukbayrak A, Kurt M, Gurel K, Gunes O, Ustun C, Akdeniz H.
    Clin Ter; 2014 Jul; 165(3):e199-204. PubMed ID: 24999574
    [Abstract] [Full Text] [Related]

  • 19. [Value of non-invasive models of liver fibrosis in judgment of treatment timing in chronic hepatitis B patients with ALT < 2×upper limit of normal].
    Zhou QQ, Hu YB, Zhou K, Zhang WW, Li MH, Dong P, Di JG, Hong L, Du QW, Xie Y, Sun QF.
    Zhonghua Gan Zang Bing Za Zhi; 2016 Sep 20; 24(9):665-670. PubMed ID: 27788722
    [Abstract] [Full Text] [Related]

  • 20. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
    Lichtinghagen R, Pietsch D, Bantel H, Manns MP, Brand K, Bahr MJ.
    J Hepatol; 2013 Aug 20; 59(2):236-42. PubMed ID: 23523583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.